156 related articles for article (PubMed ID: 33205334)
1. Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.
Farrow NE; Holl EK; Jung J; Gao J; Jung SH; Al-Rohil RN; Selim MA; Mosca PJ; Ollila DW; Antonia SJ; Tyler DS; Nair SK; Beasley GM
Ann Surg Oncol; 2021 Jul; 28(7):3501-3510. PubMed ID: 33205334
[TBL] [Abstract][Full Text] [Related]
2. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
[TBL] [Abstract][Full Text] [Related]
4. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
5. Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
Hao H; Xiao D; Pan J; Qu J; Egger M; Waigel S; Sanders MA; Zacharias W; Rai SN; McMasters KM
Ann Surg Oncol; 2017 Jan; 24(1):108-116. PubMed ID: 27663566
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
7. Unique Genes in Tumor-Positive Sentinel Lymph Nodes Associated with Nonsentinel Lymph Node Metastases in Melanoma.
Egger ME; Xiao D; Hao H; Kimbrough CW; Pan J; Rai SN; Cambon AC; Waigel SJ; Zacharias W; McMasters KM
Ann Surg Oncol; 2018 May; 25(5):1296-1303. PubMed ID: 29497912
[TBL] [Abstract][Full Text] [Related]
8. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
9. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
Persa OD; Knuever J; Mauch C; Schlaak M
J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy.
Farrow NE; Raman V; Williams TP; Nguyen KY; Tyler DS; Beasley GM
Ann Surg Oncol; 2020 Dec; 27(13):5121-5125. PubMed ID: 32314157
[TBL] [Abstract][Full Text] [Related]
11. Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma.
LeBlanc RE; Barton DT; Li Z; Angeles CV; Ernstoff MS; Bagley E; Wimmer D; Wong SL; Barth RJ; Shirai K; Yan S
Am J Surg Pathol; 2019 Jun; 43(6):755-765. PubMed ID: 31091203
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
13. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
[TBL] [Abstract][Full Text] [Related]
14. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.
Sumner WE; Ross MI; Mansfield PF; Lee JE; Prieto VG; Schacherer CW; Gershenwald JE
Cancer; 2002 Jul; 95(2):354-60. PubMed ID: 12124836
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
16. Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.
Leung AM; Morton DL; Ozao-Choy J; Hari DM; Shin-Sim M; Difronzo AL; Faries MB
JAMA Surg; 2013 Sep; 148(9):879-84. PubMed ID: 23903435
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and reproducibility of lymphatics mapping technique with sentinel lymph node biopsy in melanoma.
España MI; Signorini F; Marani M; Alcaraz A; Reimondez S; Romero ME; Obeide L
Cir Cir; 2019; 87(2):241-246. PubMed ID: 30768073
[TBL] [Abstract][Full Text] [Related]
18. Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.
Holtkamp LH; Wang S; Wilmott JS; Madore J; Vilain R; Thompson JF; Nieweg OE; Scolyer RA
Ann Surg Oncol; 2015 Sep; 22(9):2972-7. PubMed ID: 25990968
[TBL] [Abstract][Full Text] [Related]
19. A role for pelvic sentinel lymph nodes in lower extremity melanoma?
Laakkonen J; Kaarela O; Tervala T; Nuutinen H
Scand J Surg; 2023 Jun; 112(2):91-97. PubMed ID: 36715338
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]